Lakewood-Amedex Biotherapeutics annual revenue
2023
2024
2025
Lakewood-Amedex Biotherapeutics Revenue Growth & History (LABT)
Lakewood-Amedex Biotherapeutics reported $1.3M in revenue for fiscal 2025, a decrease of 40.32% from the previous fiscal year.
View full Lakewood-Amedex Biotherapeutics company overviewLakewood-Amedex Biotherapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.3M | −$848,100 | −40.32% |
| 2024 | 2024-12-31 | $2.1M | $2.1M | — |
| 2023 | 2023-12-31 | $0 | — | — |
Lakewood-Amedex Biotherapeutics quarterly revenue
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | $0 | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q4 2024 | 2024-12-31 | $0 | — | — |
Lakewood-Amedex Biotherapeutics revenue growth trends
Lakewood-Amedex Biotherapeutics's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Lakewood-Amedex Biotherapeutics source filings ↗